OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Therapeutic high affinity T cell receptor targeting a KRASG12D cancer neoantigen
Andrew J. Poole, V. Karuppiah, Annabelle Hartt, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 57
Andrew J. Poole, V. Karuppiah, Annabelle Hartt, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 57
Showing 26-50 of 57 citing articles:
Alternative Splicing: A Key Regulator in T cell Response and Cancer Immunotherapy
C.-C. Yong, Yexin Liang, Minmin Wang, et al.
Pharmacological Research (2025), pp. 107713-107713
Open Access
C.-C. Yong, Yexin Liang, Minmin Wang, et al.
Pharmacological Research (2025), pp. 107713-107713
Open Access
Immunogenomic cancer evolution: A framework to understand cancer immunosuppression
Shogo Kumagai, Yusaku Momoi, Hiroyoshi Nishikawa
Science Immunology (2025) Vol. 10, Iss. 105
Closed Access
Shogo Kumagai, Yusaku Momoi, Hiroyoshi Nishikawa
Science Immunology (2025) Vol. 10, Iss. 105
Closed Access
Identification of novel KRASG12D neoantigen specific TCRs and a strategy to eliminate off-target recognition
Xiaojian Han, Xiaxia Han, Yanan Hao, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Xiaojian Han, Xiaxia Han, Yanan Hao, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Cell-based immunotherapies for solid tumors: advances, challenges, and future directions
Ting Zhao, Jinping You, Congyue Wang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Ting Zhao, Jinping You, Congyue Wang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
STCRpy: a software suite for T cell receptor structure parsing, interaction profiling and machine learning dataset preparation
Nele P. Quast, Charlotte M. Deane, Matthew I. J. Raybould
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Nele P. Quast, Charlotte M. Deane, Matthew I. J. Raybould
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Improving outcomes of patients with pancreatic cancer
Stephan Dreyer, Philip Beer, Sunil R. Hingorani, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access
Stephan Dreyer, Philip Beer, Sunil R. Hingorani, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access
Signature Gene Mutations in Colorectal Cancer: Potential Neoantigens for Cancer Vaccines
Jong‐Seo Yoon, Haeun Moon, Yong Tark Jeon, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 10, pp. 4559-4559
Open Access
Jong‐Seo Yoon, Haeun Moon, Yong Tark Jeon, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 10, pp. 4559-4559
Open Access
Mechanism-Based Redesign of GAP to Activate Oncogenic Ras
Dénes Berta, Sascha Gehrke, Kinga Nyíri, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 37, pp. 20302-20310
Open Access | Times Cited: 9
Dénes Berta, Sascha Gehrke, Kinga Nyíri, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 37, pp. 20302-20310
Open Access | Times Cited: 9
Structural principles of peptide-centric chimeric antigen receptor recognition guide therapeutic expansion
Yi Sun, Tyler J. Florio, Sagar Gupta, et al.
Science Immunology (2023) Vol. 8, Iss. 90
Open Access | Times Cited: 7
Yi Sun, Tyler J. Florio, Sagar Gupta, et al.
Science Immunology (2023) Vol. 8, Iss. 90
Open Access | Times Cited: 7
Conformational plasticity of RAS Q61 family of neoepitopes results in distinct features for targeted recognition
Andrew C. McShan, David Flores‐Solis, Yi Sun, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Andrew C. McShan, David Flores‐Solis, Yi Sun, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Transcriptome analysis of primary adult B ‐cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosis
Mirjam Podgorica, Elsa Drivet, Jonas Krag Viken, et al.
European Journal Of Haematology (2024) Vol. 112, Iss. 5, pp. 731-742
Open Access | Times Cited: 2
Mirjam Podgorica, Elsa Drivet, Jonas Krag Viken, et al.
European Journal Of Haematology (2024) Vol. 112, Iss. 5, pp. 731-742
Open Access | Times Cited: 2
Tumor Antigens beyond the Human Exome
Lisabeth Emilius, Franziska Bremm, Amanda Katharina Binder, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4673-4673
Open Access | Times Cited: 2
Lisabeth Emilius, Franziska Bremm, Amanda Katharina Binder, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4673-4673
Open Access | Times Cited: 2
Engineered T cells for Colorectal Cancer
Nurul Ainaa Adilah Rus Bakarurraini, Ammar Akram Kamarudin, Rahman Jamal, et al.
Immunotherapy (2024) Vol. 16, Iss. 14-15, pp. 987-998
Closed Access | Times Cited: 2
Nurul Ainaa Adilah Rus Bakarurraini, Ammar Akram Kamarudin, Rahman Jamal, et al.
Immunotherapy (2024) Vol. 16, Iss. 14-15, pp. 987-998
Closed Access | Times Cited: 2
Focusing on CD8+ T-cell phenotypes: improving solid tumor therapy
Zhouchi Yao, Yayun Zeng, Cheng Liu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Zhouchi Yao, Yayun Zeng, Cheng Liu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Prospects and challenges of neoantigen applications in oncology
Ranran Shi, Ling Ran, Yuan Tian, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113329-113329
Closed Access | Times Cited: 2
Ranran Shi, Ling Ran, Yuan Tian, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113329-113329
Closed Access | Times Cited: 2
Multi-omics integrated analyzed the origin of intrahepatic mucinous cholangiocarcinoma: a case report
Xiaokang Zeng, Huohui Ou, Chong Zeng, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Xiaokang Zeng, Huohui Ou, Chong Zeng, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 3
Combination of multiple omics techniques for a personalized therapy or treatment selection
Chiara Massa, Barbara Seliger
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Chiara Massa, Barbara Seliger
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
How does TCR-T cell therapy exhibit a superior anti-tumor efficacy
Dandan Yang, Zhihui Duan, Ping Yuan, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 687, pp. 149209-149209
Closed Access | Times Cited: 3
Dandan Yang, Zhihui Duan, Ping Yuan, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 687, pp. 149209-149209
Closed Access | Times Cited: 3
Designing Multivalent and Multispecific Biologics
Jennifer J. Kang, Ayako Ohoka, Casim A. Sarkar
Annual Review of Chemical and Biomolecular Engineering (2023) Vol. 15, Iss. 1, pp. 293-314
Closed Access | Times Cited: 3
Jennifer J. Kang, Ayako Ohoka, Casim A. Sarkar
Annual Review of Chemical and Biomolecular Engineering (2023) Vol. 15, Iss. 1, pp. 293-314
Closed Access | Times Cited: 3
Targeted Therapies for Pancreatic Cancer
Michael S. Lee, Shubham Pant
Springer eBooks (2023), pp. 67-95
Closed Access | Times Cited: 2
Michael S. Lee, Shubham Pant
Springer eBooks (2023), pp. 67-95
Closed Access | Times Cited: 2
Identification and Structural Characterization of a mutant KRAS-G12V specific TCR restricted by HLA-A3
Malcolm J. W. Sim, Ken‐ichi Hanada, Zachary Stotz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Malcolm J. W. Sim, Ken‐ichi Hanada, Zachary Stotz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
SARS-CoV-2 B Epitope-Guided Neoantigen NanoVaccines Enhance Tumor-Specific CD4/CD8 T Cell Immunity Through B Cell Antigen Presentation
Chengyi Li, Shuai Mao, Zera Montemayor, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Chengyi Li, Shuai Mao, Zera Montemayor, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Overcoming immune evasion from post-translational modification of a mutant KRAS epitope to achieve TCR-engineered T cell-mediated antitumor activity
J. Lee, Emily Y. Chen, Taylor Hu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
J. Lee, Emily Y. Chen, Taylor Hu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Harnessing the power of AI in precision medicine: NGS-based therapeutic insights for colorectal cancer cohort
Victor Murcia Pienkowski, Piotr Skoczylas, Agata Zaremba, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Victor Murcia Pienkowski, Piotr Skoczylas, Agata Zaremba, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Broadening alloselectivity of T cell receptors by structure guided engineering
V. Karuppiah, Dhaval Sangani, Lorraine M. Whaley, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
V. Karuppiah, Dhaval Sangani, Lorraine M. Whaley, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
